DNAJB1 and cancer: Furthermore, recent advances in genome sequence analysis (25, 26) enabled the identification of further cancer entities (e.g. oncocytic neoplasms of the pancreas and bile duct) that express the DNAJB1-PRKACA fusion transcript (27) giving the prospect of future off-the-shelf therapies targeting the DNAJB1-PRKACA fusion in multiple cancer entities.